Cargando…
Genetically Engineered Mouse Models for Liver Cancer
Liver cancer is the fourth leading cause of cancer-related death globally, accounting for approximately 800,000 deaths annually. Hepatocellular carcinoma (HCC) is the most common type of liver cancer, comprising approximately 80% of cases. Murine models of HCC, such as chemically-induced models, xen...
Autores principales: | Cho, Kyungjoo, Ro, Simon Weonsang, Seo, Sang Hyun, Jeon, Youjin, Moon, Hyuk, Kim, Do Young, Kim, Seung Up |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016809/ https://www.ncbi.nlm.nih.gov/pubmed/31861541 http://dx.doi.org/10.3390/cancers12010014 |
Ejemplares similares
-
Pharmacological Inhibition of Sonic Hedgehog Signaling Suppresses Tumor Development in a Murine Model of Intrahepatic Cholangiocarcinoma
por: Cho, Kyungjoo, et al.
Publicado: (2021) -
High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
por: Moon, Hyuk, et al.
Publicado: (2019) -
Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background
por: Chung, Sook In, et al.
Publicado: (2016) -
Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways
por: Moon, Hyuk, et al.
Publicado: (2022) -
Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer
por: Cho, Kyung Joo, et al.
Publicado: (2021)